» Authors » Alison Clifford

Alison Clifford

Explore the profile of Alison Clifford including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 83
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ladouceur A, Ezdoglian A, Sparks J, Hudson M, Jamal S, Clifford A, et al.
Rheum Dis Clin North Am . 2024 Apr; 50(2):181-199. PMID: 38670720
Immune checkpoint inhibitors (ICIs) have greatly improved survival of several cancers with historically very poor prognosis. ICIs act by stimulating the patient's own immune system to fight cancer. Simultaneously, this...
2.
Butt I, van Eeden C, Burns K, Saxinger L, Clifford A, Redmond D, et al.
Front Public Health . 2023 Dec; 11:1301492. PMID: 38111485
Objective: To identify the factors that impact COVID-19 vaccine decision-making in vaccine-hesitant vasculitis patients, and compare their perceptions with other rheumatology patients, given existence of data suggesting rheumatology patients may...
3.
Cohen Tervaert J, van Eeden C, Butt I, Redmond D, Clifford A, Osman M, et al.
Clin Rheumatol . 2023 Apr; 42(6):1727-1728. PMID: 37004592
No abstract available.
4.
van Eeden C, Mohazab N, Redmond D, Yacyshyn E, Clifford A, Russell A, et al.
Lancet Reg Health Am . 2023 Mar; 20:100460. PMID: 36890852
Background: Persistent fatigue is a common complaint in ANCA-vasculitis (AAV) patients and has a profound impact on patient's quality of life. The symptoms associated with this fatigue mirror those found...
5.
Turgeon D, Bakowsky V, Baldwin C, Cabral D, Clements-Baker M, Clifford A, et al.
Rheumatology (Oxford) . 2023 Feb; 62(8):2646-2651. PMID: 36805625
Objective: In 2020, the Canadian Vasculitis Research Network (CanVasc) published their updated recommendations for the management of ANCA-associated vasculitides (AAV). The current addendum provides further recommendations regarding the use of...
6.
Butt I, van Eeden C, Burns K, Saxinger L, Clifford A, Cohen Tervaert J, et al.
J Rheumatol . 2022 Dec; 50(5):690-696. PMID: 36521919
Objective: To identify the factors that affect coronavirus disease 2019 (COVID-19) vaccine decision making among individuals diagnosed with a rheumatologic condition, given that previous international studies have demonstrated that a...
7.
Johnson A, Emery D, Clifford A
Diagnostics (Basel) . 2021 Nov; 11(11). PMID: 34829344
Takayasu's arteritis (TAK) is a large-vessel vasculitis that targets the aorta and its major branches. Although extracranial vascular involvement is uniformly present in this disease, the frequency of intracranial involvement...
8.
Procop G, Eng C, Clifford A, Villa-Forte A, Calabrese L, Roselli E, et al.
Pathog Immun . 2017 Aug; 2(2):228-238. PMID: 28758156
Objective: It is controversial whether microorganisms play a role in the pathogenesis of large and medium vessel vasculitides (eg, giant cell arteritis [GCA], Takayasu arteritis [TAK] and focal idiopathic aortitis...
9.
Roberts J, Clifford A
Ther Adv Chronic Dis . 2017 May; 8(4-5):69-79. PMID: 28491267
Giant cell arteritis (GCA) is a large vessel vasculitis that may be associated with significant complications such as blindness, stroke, or aortic aneurysm and dissection in a subset of patients....
10.
Clifford A, Hoffman G
Curr Opin Rheumatol . 2015 May; 27(4):397-405. PMID: 26002032
Purpose Of Review: We have summarized available evidence for and against the presence of a vascular microbiome. Studies that have attempted to detect bacteria and viruses in blood vessels in...